Table 1.
Patient | Age of onset | Initial presentation | Initial diagnosis | Disease course | Other involvement | CK (IU/l) (first visit) |
---|---|---|---|---|---|---|
P1 | 10 m | Motor delay | CMD | Chronic | Nil | 352–918 |
P2 | 3 y | Difficulty in climbing stairs, muscle pain | IM | Chronic | Nil | 6175 |
P3 | 5 y | High CK with motor clumsiness | IM | Subacute | Nil | 5453 |
P4 | 6 y | Asymptomatic high CK | MD | Chronic | Nil | 6391 |
P5 | 7 y | Slow runner | IM | Chronic | Nil | 5460 |
P6 | 10 y | Fatigue, skin rash | IM | Subacute | Fatigue, skin rash | 10 891 |
P7 | 11 y | Fatigue, skin rash | DM | Subacute | Fatigue, skin rash | 7508 |
P8 | 13 y | Difficulty in pedalling and climbing stairs | MD | Chronic | Nil | 7183 |
P9 | 9 y | Difficulty in climbing stairs | MD | Subacute | Nil | 9570 |
CK: creatine kinase; CMD: congenital muscular dystrophy; F: female; IM: inflammatory myopathy; M: male; MD: muscular dystrophy; m: months; y: years.